Featured Research

from universities, journals, and other organizations

Third Of Stunting, Quarter Of Deaths Among Toddlers In Poor Countries Could Be Prevented

Date:
January 18, 2008
Source:
London School of Hygiene & Tropical Medicine
Summary:
If existing maternal and child nutrition interventions were implemented in poor countries, cases of stunting among children under three years of age could be reduced by a third, and deaths by up to a quarter, according to new research.

If existing maternal and child nutrition interventions were implemented in poor countries, cases of stunting among children under three years of age could be reduced by a third, and deaths by up to a quarter, according to new research.

178 million children under five are stunted, and most of these live in Sub-Saharan Africa and south-central Asia. 160 million stunted children (90%) live in just 36 countries, and make up 46% of the 348 million children in those countries. In addition, 19 million children are affected by severe acute malnutrition.

Historical evidence of improvements in nutrition in developed countries has shown that stature, living standards, reduced disease exposure and education are linked, and that almost all stunting is avoidable. Stunting is difficult to reverse after the age of three, so it is important to focus on interventions in pregnancy and in young children, especially those aged under two.

In the past most nutrition programme reports and assessments have focused on weight gain rather than linear growth, and linear-growth retardation has been viewed as difficult to change. However, in the short term, about one third of stunting could be averted with existing interventions, say the authors. These include strategies to promote improved complementary feeding, micronutrient interventions, and interventions aimed at reducing the burden of disease.

In addition to reducing stunting, nutrition interventions, including breastfeeding promotion, could prevent about one quarter of child deaths in the 36 countries in which 90% of the world's stunted children live, while universal supplementation with calcium, iron and folic acid of women during pregnancy could prevent around 100,000 maternal deaths (24% of the total) and 3.12 million DALYs.

Professor Simon Cousens, of the London School of Hygiene & Tropical Medicine, is one of the authors of a paper which appears as part of the Lancet Maternal and Child Undernutrition Series. Professor Cousens, along with four other series authors, is presenting his findings at a press event at the Science Media Centre.

Professor Cousens comments: 'Much can be done now to improve the nutritional status of mothers and children with simple, evidence-based interventions. Although there are intergenerational effects of undernutrition which will take many years to eliminate, promotion of breastfeeding, improved complementary feeding practices, interventions to improve micronutrient status and interventions to reduce the burden of child disease can all have an immediate impact on child nutrition. Attention to the continuum of maternal and child undernutrition is essential to attainment of several of the Millennium Development Goals and must be prioritised globally and within countries. Countries with a high prevalence of undernutrition must decide which interventions should be given the highest priority, and ensure their effective implementation at high coverage to achieve the greatest benefit."


Story Source:

The above story is based on materials provided by London School of Hygiene & Tropical Medicine. Note: Materials may be edited for content and length.


Cite This Page:

London School of Hygiene & Tropical Medicine. "Third Of Stunting, Quarter Of Deaths Among Toddlers In Poor Countries Could Be Prevented." ScienceDaily. ScienceDaily, 18 January 2008. <www.sciencedaily.com/releases/2008/01/080116202020.htm>.
London School of Hygiene & Tropical Medicine. (2008, January 18). Third Of Stunting, Quarter Of Deaths Among Toddlers In Poor Countries Could Be Prevented. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/01/080116202020.htm
London School of Hygiene & Tropical Medicine. "Third Of Stunting, Quarter Of Deaths Among Toddlers In Poor Countries Could Be Prevented." ScienceDaily. www.sciencedaily.com/releases/2008/01/080116202020.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins